SLCO1B1 c.521T>C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients
出版年份 2022 全文链接
标题
SLCO1B1 c.521T>C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients
作者
关键词
-
出版物
Drug Metabolism and Personalized Therapy
Volume -, Issue -, Pages -
出版商
Walter de Gruyter GmbH
发表日期
2022-09-28
DOI
10.1515/dmpt-2022-0131
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis
- (2021) Jeong Yee et al. CLINICAL THERAPEUTICS
- Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas
- (2021) Adem Y. Dawed et al. DIABETES CARE
- Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers
- (2021) Clinical Diabetes
- Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update
- (2020) Lorraine Lipscombe et al. Canadian Journal of Diabetes
- Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
- (2018) Yu Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population
- (2018) Qi Pei et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide
- (2018) Fayou Yang et al. Scientific Reports
- Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas
- (2017) Michelle Kim et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?
- (2017) Choon Ok Kim et al. Drug Design Development and Therapy
- CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes
- (2016) Adem Y. Dawed et al. DIABETES CARE
- Management of type 2 diabetes in adults: summary of updated NICE guidance
- (2016) Hugh McGuire et al. BMJ-British Medical Journal
- Management of type 2 diabetes in adults: summary of updated NICE guidance
- (2016) Hugh McGuire et al. BMJ-British Medical Journal
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients
- (2014) Jasna Klen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C9*2 Allele Increases Risk for Hypoglycemia in POR*1/*1 Type 2 Diabetic Patients Treated with Sulfonylureas
- (2014) G. Ragia et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population
- (2014) E. Giannakopoulou et al. MOLECULAR BIOLOGY REPORTS
- International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms
- (2013) K M Giacomini et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- OATP1B3 Is Expressed in Pancreatic -Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide
- (2013) H. E. Meyer zu Schwabedissen et al. DIABETES
- Organic Anion Transporting Polypeptides Expressed in Pancreatic Cancer May Serve As Potential Diagnostic Markers and Therapeutic Targets for Early Stage Adenocarcinomas
- (2013) Amanda Hays et al. PHARMACEUTICAL RESEARCH
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated Type 2 diabetic patients
- (2012) Georgia Ragia et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers
- (2012) Yu Cheng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting
- (2011) Osman Gökalp et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity
- (2011) Ute I. Schwarz et al. Pharmacogenetics and Genomics
- Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective
- (2011) Vangelis G Manolopoulos et al. PHARMACOGENOMICS
- Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
- (2011) M. Niemi et al. PHARMACOLOGICAL REVIEWS
- Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets
- (2011) Evangelos Briasoulis et al. OncoTargets and Therapy
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
- (2009) N Picard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Presence ofCYP2C9*3allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- (2009) Georgia Ragia et al. PHARMACOGENOMICS
- Influence of Drug Transporters and UGT Polymorphisms on Pharmacokinetics of Phenolic glucuronide Metabolite of Mycophenolic Acid in Japanese Renal Transplant Recipients
- (2008) Masatomo Miura et al. THERAPEUTIC DRUG MONITORING
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now